RxSight (RXST) Non Operating Interest Expenses (2020 - 2026)

RxSight (RXST) has reported Non Operating Interest Expenses for 7 consecutive years, with $3000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses fell 40.0% year-over-year to $3000.0; the trailing twelve-month figure through Jun 2026 stood at $15000.0 (down 28.57% YoY), and the FY2025 full-year result was $19000.0, down 9.52% from the prior year.
• Non Operating Interest Expenses was little changed at $3000.0 in Q2 2026 per RXST's latest filing, from $3000.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $1.6 million in Q2 2023 and bottomed at $3000.0 in Q1 2026.
• Historically, Non Operating Interest Expenses has averaged $461277.8 across 5 years, with a median of $6000.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses jumped 51.86% in 2022, then tumbled 99.72% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $1.5 million in 2022, then slumped by 99.72% to $4000.0 in 2023, then increased by 25.0% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025, then tumbled by 40.0% to $3000.0 in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $3000.0, $3000.0, and $5000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.